These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 14986695)

  • 1. Valvular health disease with pergolide.
    Prescrire Int; 2003 Dec; 12(68):225. PubMed ID: 14986695
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinson's drugs linked to heart valve trouble.
    Harv Heart Lett; 2007 Apr; 17(8):7. PubMed ID: 17402160
    [No Abstract]   [Full Text] [Related]  

  • 3. Pergolide in Parkinson's disease: time for a change?
    Grosset KA; Grosset DG
    Lancet; 2004 Jun; 363(9424):1907-8. PubMed ID: 15183636
    [No Abstract]   [Full Text] [Related]  

  • 4. Heart valve regurgitation, pergolide use, and parkinson disease: an observational study and meta-analysis.
    Corvol JC; Anzouan-Kacou JB; Fauveau E; Bonnet AM; Lebrun-Vignes B; Girault C; Agid Y; Lechat P; Isnard R; Lacomblez L
    Arch Neurol; 2007 Dec; 64(12):1721-6. PubMed ID: 18071034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart valvular disease in patients with Parkinson's disease treated with high-dose pergolide.
    Van Camp G; Flamez A; Cosyns B; Goldstein J; Perdaens C; Schoors D
    Neurology; 2003 Sep; 61(6):859-61. PubMed ID: 14504342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pergolide associated valvulopathy: critical analysis of the literature and practical recommendations].
    Corvol JC; Schüpbach M; Bonnet AM;
    Rev Neurol (Paris); 2005 Jul; 161(6-7):637-43. PubMed ID: 16141947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs and valvular heart disease.
    Roth BL
    N Engl J Med; 2007 Jan; 356(1):6-9. PubMed ID: 17202450
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiac valve regurgitation with pergolide compared with nonergot agonists in Parkinson disease.
    Dewey RB; Reimold SC; O'Suilleabhain PE
    Arch Neurol; 2007 Mar; 64(3):377-80. PubMed ID: 17353380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pergolide use in Parkinson disease is associated with cardiac valve regurgitation.
    Baseman DG; O'Suilleabhain PE; Reimold SC; Laskar SR; Baseman JG; Dewey RB
    Neurology; 2004 Jul; 63(2):301-4. PubMed ID: 15277624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac valvulopathy associated with pergolide use.
    Zadikoff C; Rochon P; Lang A
    Can J Neurol Sci; 2006 Feb; 33(1):27-33. PubMed ID: 16583718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminagonists and fibrotic valvular heart disease: further considerations.
    Rascol O; Pathak A; Bagheri H; Montastruc JL
    Mov Disord; 2004 Dec; 19(12):1524-5. PubMed ID: 15515031
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cardiac valvulopathy and dopamine agonist].
    Grandas F
    Neurologia; 2007 Dec; 22(10):870-81. PubMed ID: 17671852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pergolide use and heart valve fibrosis. Yearly control in patients with Parkinson disease who use pergolide].
    van Laar T; Berendse H; Bloem BR; Boon AJ; van Hilten JJ; Hovestadt A; de Koning-Tijssen MA; Nijssen PC; Weber WE
    Ned Tijdschr Geneeskd; 2009 Jan; 153(3):87-90. PubMed ID: 19235345
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopamine agonists and valvular heart disease.
    Linkova H; Ruzicka E; Penicka M
    N Engl J Med; 2007 Apr; 356(16):1676; author reply 1678-80. PubMed ID: 17447279
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-related valvular heart disease: here we go again: will we do better this time?
    Rahimtoola SH
    Mayo Clin Proc; 2002 Dec; 77(12):1275-7. PubMed ID: 12479510
    [No Abstract]   [Full Text] [Related]  

  • 16. [Severe insuffiency of the aortic and tricuspidal valves associated with pergolide use].
    van Strater AC; Bax JJ; van Hilten JJ; Jukema JW
    Ned Tijdschr Geneeskd; 2005 Apr; 149(16):891-4. PubMed ID: 15868996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valvular heart disease in patients taking pergolide.
    Pritchett AM; Morrison JF; Edwards WD; Schaff HV; Connolly HM; Espinosa RE
    Mayo Clin Proc; 2002 Dec; 77(12):1280-6. PubMed ID: 12479512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pergolide associated cardiac valvulopathy based on Ontario administrative data.
    Zadikoff C; Duong-Hua M; Sykora K; Marras C; Lang A; Rochon P
    Can J Neurol Sci; 2008 May; 35(2):173-8. PubMed ID: 18574930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Awareness of potential valvulopathy risk with pergolide and changes in clinical practice after label change: a survey among European neurologists.
    Lledó A; Dellva MA; Strombom IM; Wilkie JL; Jungemann ME; Royer MG; Simmons VE; Cavazzoni PA
    Eur J Neurol; 2007 Jun; 14(6):644-9. PubMed ID: 17539942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New concerns about old drugs: Valvular heart disease on ergot derivative dopamine agonists as an exemplary situation of pharmacovigilance.
    Rascol O; Pathak A; Bagheri H; Montastruc JL
    Mov Disord; 2004 Jun; 19(6):611-3. PubMed ID: 15197697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.